Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: a pooled analysis
Authors:
- Elizabeth J WilliamsonEWElizabeth J Williamson
- Manon van EngelandMEManon van Engeland
- M. A. JenkinsMJM. A. Jenkins
- Graham G GilesGGGraham G Giles
- John L HopperJHJohn L Hopper
- Melissa C SoutheyMSMelissa C Southey
- Joanne P YoungJYJoanne P Young
- Daniel D BuchananDBDaniel D Buchanan
- Michael D WalshMWMichael D Walsh
- Piet A van Den BrandtPBPiet A van Den Brandt
- R. Alexandra GoldbohmRGR. Alexandra Goldbohm
Open Access
- 24 April 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 41 (4) , 1060-1072
Abstract
Background How body size influences risk of molecular subtypes of colorectal cancer (CRC) is unclear. We investigated whether measures of anthropometry differentially influence risk of tumours according to BRAF c.1799T>A p.V600E mutation (BRAF) and microsatellite instability (MSI) status. Methods Data from The Netherlands Cohort Study (n = 120 852) and Melbourne Collaborative Cohort Study (n = 40 514) were pooled and included 734 and 717 colorectal cancer cases from each study, respectively. Hazard ratios (HRs) and 95% confidence intervals (CIs) for body mass index (BMI), waist measurement and height were calculated and compared for subtypes defined by BRAF mutation and MSI status, measured from archival tissue. Results Results were consistent between studies. When pooled, BMI modelled in 5 kg/m2 increments was positively associated with BRAF wild-type (HR: 1.16, 95% CI: 1.08–1.26) and MS-stable tumours (HR: 1.15, 95% CI: 1.06–1.24). Waist measurement was also associated with BRAF wild-type (highest vs lowest quartile, HR: 1.59, 95% CI: 1.33–1.90) and MS-stable tumours (highest vs lowest quartile HR: 1.68, 95% CI: 1.31–2.15). The HRs for BRAF mutation tumours and MSI tumours were smaller and non-significant, but differences between the HRs by tumour subtypes were not significant. Height, modelled per 5-cm increase, was positively associated with BRAF wild-type and BRAF mutation tumours, but the HR was greater for tumours with a BRAF mutation than BRAF wild-type (HR: 1.23, 95% CI: 1.11–1.37, Pheterogeneity = 0.03). Similar associations were observed with respect to height and MSI tumours (HR: 1.26, 95% CI: 1.13–1.40, Pheterogeneity = 0.02). Conclusions Generally, overweight increases the risk of CRC. Taller individuals have an increased risk of developing a tumour with a BRAF mutation or MSI.Keywords
This publication has 53 references indexed in Scilit:
- Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldGut, 2010
- Case–Control Study of Overweight, Obesity, and Colorectal Cancer Risk, Overall and by Tumor Microsatellite Instability StatusJNCI: Journal of the National Cancer Institute, 2010
- Lifestyle Factors and Microsatellite Instability in Colorectal Cancer: The Evolving Field of Molecular Pathological EpidemiologyJNCI: Journal of the National Cancer Institute, 2010
- Serrated Polyps and Colorectal Cancer: New Pathway to MalignancyAnnual Review of Pathology: Mechanisms of Disease, 2009
- Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 CasesCancer Research, 2008
- Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancerProceedings of the National Academy of Sciences, 2007
- Classification of colorectal cancer based on correlation of clinical, morphological and molecular featuresHistopathology, 2006
- CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancerNature Genetics, 2006
- Epigenetic events and protection from colon cancer in New ZealandEnvironmental and Molecular Mutagenesis, 2004
- CpG island methylator phenotype in colorectal cancerProceedings of the National Academy of Sciences, 1999